MJ and all; WSJ 12/2/97
Arris Pharma Gets Patent For Protease Inhibition Tech
Dow Jones Newswires
SOUTH SAN FRANCISCO, Calif. -- Arris Pharmaceutical Corp. (ARRS) received a patent for a broad method of protease inhibition, Delta Technology, from the U.S. Patent and Trademark Office.
In a press release Tuesday, the company said the patent encompasses technology relating to methods useful in research for the discovery of novel protease inhibitors, for identifying structural activity relationships of protease inhibitors, and for screening molecules against specific enzyme targets.
The technology could also be useful for developing potent, selective small molecule protease inhibitors that have the potential to treat diseases associated with protease activity, Arris said.
The company said Delta Technology is the cornerstone of five of its eight collaborations.
The Patent No. 5,693,515, entitled "Metal Complexed Serine Protease Inhibitors," was filed by the company in May 1995.
Arris Pharmaceutical is an integrated drug discovery company. |
